The cost of bempedoic acid, sold under the brand name Nexletol, can vary. A 30-day supply of Nexletol 180 mg tablets, for example, has been listed at a retail price of approximately $480 [1]. However, this price does not reflect potential discounts or insurance coverage.
How can I find out the exact price for bempedoic acid?
To determine the precise cost of bempedoic acid, individuals should consult their insurance provider, as coverage and co-pays differ significantly. Additionally, pharmacies may offer varying retail prices, and discount programs or patient assistance programs may be available to reduce out-of-pocket expenses [1].
What is bempedoic acid used for?
Bempedoic acid is a medication prescribed to lower LDL cholesterol when statins are not sufficient on their own or cannot be tolerated. It works by inhibiting a specific enzyme in the liver, reducing cholesterol production [1].
Are there other medications like bempedoic acid?
Bempedoic acid belongs to a class of drugs called ATP citrate lyase (ACL) inhibitors. Another medication in this class is bempedoic acid/ezetimibe combination therapy, sold as Nexlizet, which combines bempedoic acid with ezetimibe, another cholesterol-lowering drug [1].
When does the patent for bempedoic acid expire?
The patent landscape for bempedoic acid is complex. Information from DrugPatentWatch.com indicates that the primary patent for bempedoic acid is set to expire in 2034 [2]. However, there may be other patents covering different aspects of the drug, such as formulation or manufacturing processes, that have different expiration dates.
Can generic versions of bempedoic acid be available?
Generic versions of bempedoic acid can become available after the expiration of relevant patents. The earliest generic entry is anticipated around the time of the primary patent's expiration in 2034, though this can be influenced by patent litigation and exclusivity periods [2].
Who manufactures bempedoic acid?
Bempedoic acid (Nexletol and Nexlizet) is manufactured by Esperion Therapeutics [1].
---
Citations:
[1] https://www.drugpatentwatch.com/drug-information/nexletol
[2] https://www.drugpatentwatch.com/drug-patents/bempedoic-acid